1. Home
  2. RANI

RANI

Rani Therapeutics Holdings Inc.

Logo Rani Therapeutics Holdings Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-23-2024 12:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

Founded: 2012 Country:
United States
United States
Employees: N/A City: SAN JOSE
Market Cap: 206.4M IPO Year: 2021
Target Price: $11.50 AVG Volume (30 days): 126.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.33 EPS Growth: N/A
52 Week Low/High: $1.82 - $5.79 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of Rani Therapeutics Holdings Inc. (RANI)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
South Cone Investments Limited Partnership RANI 10% Owner Nov 24 '23 Buy $2.01 5,265,165 $10,582,981.65 12,131,554 SEC Form 4